Impinj, Inc. 8-K: Officer & Director Changes
Ticker: PI · Form: 8-K · Filed: Dec 22, 2025 · CIK: 1114995
Sentiment: neutral
Topics: leadership-change, officer-appointment, director-election, compensation
TL;DR
Impinj's 8-K details officer/director changes and compensation.
AI Summary
Impinj, Inc. filed an 8-K on December 22, 2025, reporting events as of December 19, 2025. The filing pertains to the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers.
Why It Matters
Changes in a company's board of directors or executive officers can signal shifts in strategy, governance, or operational focus.
Risk Assessment
Risk Level: medium — Changes in key leadership and compensation arrangements can impact company strategy and investor confidence.
Key Numbers
- 2025-12-19 — Event Date (Date of earliest event reported)
- 2025-12-22 — Filing Date (Date the 8-K was filed)
Key Players & Entities
- Impinj, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Seattle, Washington (location) — Principal executive offices
FAQ
What specific officer or director positions were affected by the changes reported in this 8-K?
The filing indicates changes related to 'Departure of Directors or Certain Officers', 'Election of Directors', and 'Appointment of Certain Officers', but does not specify the names or exact positions in the provided text.
Are the compensatory arrangements mentioned for specific named officers?
The filing states 'Compensatory Arrangements of Certain Officers' as an item information, but the specific details of these arrangements and the officers involved are not detailed in the provided excerpt.
When was the earliest event reported in this 8-K?
The earliest event reported in this 8-K was on December 19, 2025.
What is Impinj, Inc.'s principal executive office address?
Impinj, Inc.'s principal executive offices are located at 400 Fairview Avenue North, Suite 1200, Seattle, Washington 98109.
What is the SEC Act under which this 8-K is filed?
This 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 1,740 words · 7 min read · ~6 pages · Grade level 19.4 · Accepted 2025-12-22 16:10:25
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share PI The Nasdaq Global Sele
Filing Documents
- pi-20251219.htm (8-K) — 78KB
- 0001193125-25-328739.txt ( ) — 192KB
- pi-20251219.xsd (EX-101.SCH) — 30KB
- pi-20251219_htm.xml (XML) — 5KB
02
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Amendment to Executive Employment Agreement On December 19, 2025, Impinj, Inc. (the "Company") entered into a Second Amendment to Employment Agreement (the "Amendment") with Chris Diorio, Ph.D., the Company's Chief Executive Officer, which, in addition to certain other clarifications, modifies Dr. Diorio's eligibility for severance payments and benefits in the event of certain qualifying terminations of employment. Except as provided in the Amendment, the terms of Dr. Diorio's existing executive employment agreement with the Company, as previously amended (the "Employment Agreement"), remain in effect. Pursuant to the Amendment, if, within the period commencing three months prior to and ending 12 months following a Change of Control (as defined in the Employment Agreement) (the "Change of Control Period"), Dr. Diorio's employment is terminated either (1) by the Company other than for Cause (as defined in the Employment Agreement), death or Disability (as defined in the Employment Agreement), or (2) by Dr. Diorio's resignation for Good Reason (as defined in the Employment Agreement) (in either case, a "Qualified Termination"), he will become eligible to receive the following severance benefits and payments, in each case subject to applicable withholdings: a lump sum payment equal to 200% of his base salary as then in effect, in accordance with the Company's normal payroll policies; full accelerated vesting of all outstanding time-based Company equity awards; reimbursement for the cost of continuing group health insurance coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended ("COBRA" and such reimbursement, "COBRA Severance") for him and his eligible covered dependents for up to twenty-four months; the earned portion of his annual performance bonus for the year of t